Moleculin Announces Reminder for Conference Call to Discuss Positive Developments Regarding Annamycin
HOUSTON, TX--(Marketwired - October 20, 2016) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, …